Immunogenicity is the ability of a particular substance induce a humoral and/or cell-mediated immune responses. An immune response can be potentially elicited by administering any substance into the human body.
Products which increase the potential of anti-drug antibodies include :
Therapeutic antibodies, enzyme therapies, peptides and combination products.
An immune response may also impact a drug’s safety and efficacy. Assays should be designed in such a way that they provide sufficient sensitivity and are free from potential risks to the target patient population. By designing assays with these factors, it is possible to gather data about the strength and type of immune response that a drug may produce in humans.
- Bridging ELISA
- Type II hypersensitivity reaction
- Clinical Trial Support
- Total Antibody Assay
- Enzyme Linked Immuno Sorbent Assay (ELISA)
Related Conference of Immunogenicity Testing
Immunogenicity Testing Conference Speakers